Clifford Chance has advised Marinomed Biotech AG on the company’s successful IPO. The company was listed on the official market (prime market segment) of the Vienna…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now